YPQ

4,4,4-tris(fluoranyl)-1-[3-(trifluoromethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]butan-1-one

Created:	2023-12-08
Last modified:	2025-10-29

Find Related PDB Entry
1 entries where YPQ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	0
Bond Count	37
Aromatic Bond Count	0

2D diagram of YPQ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4,4,4-tris(fluoranyl)-1-[3-(trifluoromethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]butan-1-one
Systematic Name (OpenEye OEToolkits)	4,4,4-tris(fluoranyl)-1-[3-(trifluoromethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]butan-1-one
Formula	C₁₂ H₁₄ F₆ N₂ O₂
Molecular Weight	332.242
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	FC(F)(F)CCC(=O)N1CCC2(CC1)CC(=NO2)C(F)(F)F
SMILES	OpenEye OEToolkits	2.0.7	C1CN(CCC12CC(=NO2)C(F)(F)F)C(=O)CCC(F)(F)F
Canonical SMILES	CACTVS	3.385	FC(F)(F)CCC(=O)N1CCC2(CC1)CC(=NO2)C(F)(F)F
Canonical SMILES	OpenEye OEToolkits	2.0.7	C1CN(CCC12CC(=NO2)C(F)(F)F)C(=O)CCC(F)(F)F
InChI	InChI	1.06	InChI=1S/C12H14F6N2O2/c13-11(14,15)2-1-9(21)20-5-3-10(4-6-20)7-8(19-22-10)12(16,17)18/h1-7H2
InChIKey	InChI	1.06	ZEAVKHMQTZBUND-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB21561
Name	Alpibectir
Groups	investigational
Description	Alpibectir is a small molecule drug. Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide). Alpibectir has a monoisotopic molecular weight of 332.1 Da.
Synonyms	Alpibectir
CAS number	2285440-39-1

Related Resource References

Resource Name	Reference
PubChem	137500045
ChEMBL	CHEMBL5095086

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.